Business & Finance
Cytogen reports net loss of $5.7 million in third quarter
Published in Women's Health Weekly, December 7th, 2006
The company also reiterated plans for the U.S. launch of Caphosol in early 2007. Approved as a prescription medical device, Caphosolis a topical oral agent for the treatment of oral mucositis and dry mouth. Caphosol was acquired by Cytogen in October 2006 and represents its fourth approved oncology product in the United States.
Cytogen reported a net loss of $5.7 million, or $0.26 per basic and diluted share for the third quarter of 2006, compared to a net loss of $7.1 million, or $0.40 per basic and diluted share,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Allergy & Immunology
Women who have vaginal itching, burning and other symptoms may be allergic to their partner's semen - Cervical Cancer
Study finds HPV test better predictor of cervical cancer than Pap smear in older women - Mental Health
Fatigue in women is reduced in stress-related cortisol study - Urology
Study confirms safety, effectiveness of Renessa procedure for female incontinence - Uterine Fibroids
More women with fibroids discussing uterine fibroid embolization with physicians - Angiogenesis
Investigators at University of Texas, M.D. Anderson Cancer Center release new data on angiogenesis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
